Equity: the next frontier in climate talks

Not rebuilding for tomorrow

The Bhopal legacy: reworking corporate liability

Loud and unclear

Ethics on trial

Five per cent of the clinical trials conducted across the world will be in India by 2012. They are vital for confirming the efficacy of a new drug,…

Science and Technology - Briefs

Science and Technology - Briefs

The real pandemic

Control your food. It is your business

The civil spring

Have an aggressive government and an overreaching judiciary curbed dissent?

News 360° - Briefs

World gets a yellow card

The Warsaw climate talks serve a grim warning to the world that inaction will cost, writes Chandra Bhushan as he leaves Warsaw just before the …

Science and Technology - Briefs

Power games at UN climate talks

Climate talks unfolded amid high drama. Developing countries protested inaction by developed countries, civil society organisations walked out, …

Clouds over solar

Clash of the cyberworlds

In an increasingly digital world, the issue of Internet freedom and governance has become hugely contested. Censorship and denial of access occur …

The Avon lady lifts our biodiversity

Loopholes in the Biological Diversity Act being used to export India’s genetic material

With a pinch of salt

Fast food can be made less salty, finds research. But companies refuse to do so

Trade barred

Countries protect their renewable energy equipment. Exporting nations see it as trade barrier  

Battle for the Internet

As the Internet becomes the public square and the marketplace of our world, it is increasingly becoming a contested terrain. Its potential for …

Science and Technology - Briefs

Science & Technology - Briefs

How competent is Indian science?

A shoddy inter-academy report on GM crops casts a shadow on the integrity and competence of Indian science, while a US expert finds approval for …

Science and Technology - Briefs

Science and Technology - Briefs